301 related articles for article (PubMed ID: 26262748)
1. [GENETIC AND METABOLIC URGENCIES IN THE NEONATAL INTENSIVE CARE UNIT: MAPLE SYRUP URINE DISEASE].
Páez Rojas PL; Suarez Obando F
Nutr Hosp; 2015 Jul; 32(1):420-5. PubMed ID: 26262748
[TBL] [Abstract][Full Text] [Related]
2. [Maple Syrup Urine Disease in a newborn infant].
Mazur A; Sykut-Cegielska J; Ciebiera M; Trzeciak J; Taybert J; Kowalik A; Ołtarzewski M
Med Wieku Rozwoj; 2007; 11(1):65-8. PubMed ID: 17965467
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis of MSUD by newborn screening allows early intervention without extraneous detoxification.
Heldt K; Schwahn B; Marquardt I; Grotzke M; Wendel U
Mol Genet Metab; 2005 Apr; 84(4):313-6. PubMed ID: 15781191
[TBL] [Abstract][Full Text] [Related]
4. Acrodermatitis dysmetabolica in an infant with maple syrup urine disease.
Flores K; Chikowski R; Morrell DS
Clin Exp Dermatol; 2016 Aug; 41(6):651-4. PubMed ID: 27334242
[TBL] [Abstract][Full Text] [Related]
5. Implications of Maple Syrup Urine Disease in Newborns.
Harris-Haman P; Brown L; Massey S; Ramamoorthy S
Nurs Womens Health; 2017; 21(3):196-206. PubMed ID: 28599741
[TBL] [Abstract][Full Text] [Related]
6. Production and characterization of murine models of classic and intermediate maple syrup urine disease.
Homanics GE; Skvorak K; Ferguson C; Watkins S; Paul HS
BMC Med Genet; 2006 Mar; 7():33. PubMed ID: 16579849
[TBL] [Abstract][Full Text] [Related]
7. Branched-chain α-ketoacid dehydrogenase deficiency (maple syrup urine disease): Treatment, biomarkers, and outcomes.
Strauss KA; Carson VJ; Soltys K; Young ME; Bowser LE; Puffenberger EG; Brigatti KW; Williams KB; Robinson DL; Hendrickson C; Beiler K; Taylor CM; Haas-Givler B; Chopko S; Hailey J; Muelly ER; Shellmer DA; Radcliff Z; Rodrigues A; Loeven K; Heaps AD; Mazariegos GV; Morton DH
Mol Genet Metab; 2020 Mar; 129(3):193-206. PubMed ID: 31980395
[TBL] [Abstract][Full Text] [Related]
8. Brain Branched-Chain Amino Acids in Maple Syrup Urine Disease: Implications for Neurological Disorders.
Xu J; Jakher Y; Ahrens-Nicklas RC
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33050626
[TBL] [Abstract][Full Text] [Related]
9. Adipose transplant for inborn errors of branched chain amino acid metabolism in mice.
Zimmerman HA; Olson KC; Chen G; Lynch CJ
Mol Genet Metab; 2013 Aug; 109(4):345-53. PubMed ID: 23800641
[TBL] [Abstract][Full Text] [Related]
10. [Progress of research on Maple syrup disease].
Yang C; Chen T; Lei X; Liu Y; Xu M; Yang D
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2019 Jul; 36(7):737-741. PubMed ID: 31302925
[TBL] [Abstract][Full Text] [Related]
11. Markers associated with inborn errors of metabolism of branched-chain amino acids and their relevance to upper levels of intake in healthy people: an implication from clinical and molecular investigations on maple syrup urine disease.
Mitsubuchi H; Owada M; Endo F
J Nutr; 2005 Jun; 135(6 Suppl):1565S-70S. PubMed ID: 15930470
[TBL] [Abstract][Full Text] [Related]
12. EEG Pattern in Neonatal Maple Syrup Urine Disease: Description and Clinical Significance.
Poothrikovil RP; Al Thihli K; Al Futaisi A
Neurodiagn J; 2021 Sep; 61(3):123-131. PubMed ID: 34449278
[TBL] [Abstract][Full Text] [Related]
13. Neonatal case of classic maple syrup urine disease: usefulness of (1) H-MRS in early diagnosis.
Sato T; Muroya K; Hanakawa J; Asakura Y; Aida N; Tomiyasu M; Tajima G; Hasegawa T; Adachi M
Pediatr Int; 2014 Feb; 56(1):112-5. PubMed ID: 24548198
[TBL] [Abstract][Full Text] [Related]
14. Intermittent maple syrup urine disease: two case reports.
Axler O; Holmquist P
Pediatrics; 2014 Feb; 133(2):e458-60. PubMed ID: 24394677
[TBL] [Abstract][Full Text] [Related]
15. Treatment of maple syrup urine disease with high flow hemodialysis in a neonate.
Aygün F; Kıykım E; Aktuğlu-Zeybek Ç; Zubarioğlu T; Cam H
Turk J Pediatr; 2019; 61(1):107-110. PubMed ID: 31559730
[TBL] [Abstract][Full Text] [Related]
16. Total branched-chain amino acids requirement in patients with maple syrup urine disease by use of indicator amino acid oxidation with L-[1-13C]phenylalanine.
Riazi R; Rafii M; Clarke JT; Wykes LJ; Ball RO; Pencharz PB
Am J Physiol Endocrinol Metab; 2004 Jul; 287(1):E142-9. PubMed ID: 14970005
[TBL] [Abstract][Full Text] [Related]
17. An early diagnosis leads to a good prognosis: a patient with maple syrup urine disease--screened by tandem mass spectrometry.
Lin JF; Chiu PC; Hsu HY; Lin SM; Chen YY; Hsieh KS
Acta Paediatr Taiwan; 2004; 45(5):287-9. PubMed ID: 15868812
[TBL] [Abstract][Full Text] [Related]
18. Maple syrup urine disease: favourable effect of early diagnosis by newborn screening on the neonatal course of the disease.
Simon E; Fingerhut R; Baumkötter J; Konstantopoulou V; Ratschmann R; Wendel U
J Inherit Metab Dis; 2006 Aug; 29(4):532-7. PubMed ID: 16817013
[TBL] [Abstract][Full Text] [Related]
19. Eleven novel mutations of the BCKDHA, BCKDHB and DBT genes associated with maple syrup urine disease in the Chinese population: Report on eight cases.
Li X; Ding Y; Liu Y; Ma Y; Song J; Wang Q; Li M; Qin Y; Yang Y
Eur J Med Genet; 2015 Nov; 58(11):617-23. PubMed ID: 26453840
[TBL] [Abstract][Full Text] [Related]
20. Successful treatment of severe MSUD in Bckdhb
Pontoizeau C; Gaborit C; Tual N; Simon-Sola M; Rotaru I; Benoist M; Colella P; Lamazière A; Brassier A; Arnoux JB; Rötig A; Ottolenghi C; de Lonlay P; Mingozzi F; Cavazzana M; Schiff M
J Inherit Metab Dis; 2024 Jan; 47(1):41-49. PubMed ID: 36880392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
